- Home
- FLNC vs FLGT Comparison
FLNC vs FLGT Comparison
Compare FLNC & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNC
- FLGT
- Stock Information
- Founded
- FLNC 2018
- FLGT 2011
- Country
- FLNC United States
- FLGT United States
- Employees
- FLNC N/A
- FLGT N/A
- Industry
- FLNC Industrial Machinery/Components
- FLGT Medical Specialities
- Sector
- FLNC Miscellaneous
- FLGT Health Care
- Exchange
- FLNC Nasdaq
- FLGT Nasdaq
- Market Cap
- FLNC 533.2M
- FLGT 639.0M
- IPO Year
- FLNC 2021
- FLGT 2016
- Fundamental
- Price
- FLNC $5.83
- FLGT $19.53
- Analyst Decision
- FLNC Buy
- FLGT Buy
- Analyst Count
- FLNC 18
- FLGT 2
- Target Price
- FLNC $9.03
- FLGT $24.00
- AVG Volume (30 Days)
- FLNC 4.0M
- FLGT 256.3K
- Earning Date
- FLNC 08-06-2025
- FLGT 08-01-2025
- Dividend Yield
- FLNC N/A
- FLGT N/A
- EPS Growth
- FLNC N/A
- FLGT N/A
- EPS
- FLNC N/A
- FLGT N/A
- Revenue
- FLNC $2,329,871,000.00
- FLGT $292,448,000.00
- Revenue This Year
- FLNC $3.61
- FLGT $11.79
- Revenue Next Year
- FLNC $25.79
- FLGT $10.45
- P/E Ratio
- FLNC N/A
- FLGT N/A
- Revenue Growth
- FLNC 6.08
- FLGT 1.71
- 52 Week Low
- FLNC $3.46
- FLGT $14.57
- 52 Week High
- FLNC $24.00
- FLGT $25.11
- Technical
- Relative Strength Index (RSI)
- FLNC 67.78
- FLGT 40.94
- Support Level
- FLNC $4.68
- FLGT $20.30
- Resistance Level
- FLNC $5.98
- FLGT $21.07
- Average True Range (ATR)
- FLNC 0.37
- FLGT 0.69
- MACD
- FLNC 0.10
- FLGT -0.25
- Stochastic Oscillator
- FLNC 78.16
- FLGT 1.15
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.